Larimar Therapeutics Inc.

Larimar Therapeutics Inc.

Biotechnology United States 74 employees LRMR
Employees
74
Contacts
3
Emails
3
Phones
2

Larimar Therapeutics Inc. Overview

Headquarters
United States
Phone Number
Available in AeroLeads
Website
larimartx.com
Industry
Biotechnology
Employees
74
Founded
2016
Stock Symbol
LRMR
Company Email
Available in AeroLeads

About Larimar Therapeutics Inc.

Larimar Therapeutics, Inc. (Nasdaq:LRMR), is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. The company’s lead compound, CTI-1601, is currently being evaluated in a Phase 1 clinical program as a potential treatment for Friedreich’s ataxia, a rare and progressive genetic disease. Larimar also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds. For more information, please visit: https://larimartx.com.

Larimar Therapeutics Inc. Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
2
50.0% coverage

Larimar Therapeutics Inc. Org Chart

Sample employees and titles
Name Title Contact
John Berman, Cfa, Cpa Vice President, Finance and Operations
Email Phone
Keith L. Vice President, Technical Operations
View
Judith Lalonde
Email Phone
Gopi Shankar Biotechnology R&D Executive ✦ Creates
Email

Employees by Management Level

Individual contributor 5 profiles
Director 4 profiles
Executive 3 profiles
Manager 2 profiles
Senior / Lead 2 profiles
Associate / junior 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 4 4 2
IT 2 2 2
Executive 1 1 1
Marketing 1 1 0

Larimar Therapeutics Inc. Tech Stack

Cloud / infrastructure 1 profile
Data / AI 1 profile

Compare Similar Companies to Larimar Therapeutics Inc.